Brief Title
Efficacy and Safety Study of Zinc Acetate to Treat Wilson's Disease in Japan.
Official Title
Phase3,Open-label,Clinical Trial of Zinc Acetate for Treatment of Wilson's Disease in Japan.
Brief Summary
The purpose of this study is to determine whether Zinc Acetate is effective and safe in the treatment of Wilson's disease among Japanese.
Study Phase
Phase 3
Study Type
Interventional
Condition
Wison's Disease
Intervention
Zinc acetate
Publications
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
Recruitment Information
Recruitment Status
Drug
Start Date
October 2004
Completion Date
December 2005
Primary Completion Date
August 2005
Eligibility Criteria
Inclusion Criteria: - Wilson's disease(adult,infant,pregnant woman) Exclusion Criteria: - acute hepatitis - malignant tumor
Gender
All
Ages
1 Year - N/A
Accepts Healthy Volunteers
No
Contacts
Koudou Ishii, M.D., ,
Administrative Informations
NCT ID
NCT00212368
Organization ID
NPC-02-1
Study Sponsor
Nobelpharma
Study Sponsor
Koudou Ishii, M.D., Study Director, National MINAMIYOKOHAMA Hospital
Verification Date
September 2010